High HLA-DP Expression and Graft-versus-Host Disease
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Transplantation of hematopoietic cells from unrelated donors can cure blood disorders but carries a significant risk of acute graft-versus-host disease (GVHD). The risk is higher when the recipient and donor are HLA-DPB1-mismatched, but the mechanisms leading to GVHD are unknown. The HLA-DPB1 regulatory region variant rs9277534 is associated with HLA-DPB1 expression. We tested the hypothesis that the GVHD risk correlates with the rs9277534 allele linked to the mismatched HLA-DPB1 in the recipient. METHODS: We genotyped rs9277534 in 3505 persons to define rs9277534-DPB1 haplotypes. Among 1441 recipients of transplants from HLA-A,B,C,DRB1,DQB1-matched unrelated donors with only one HLA-DPB1 mismatch, linkage of the rs9277534 A and G alleles to the mismatched HLA-DPB1 was determined. HLA-DPB1 expression was assessed by means of a quantitative polymerase-chain-reaction assay. The risk of acute GVHD among recipients whose mismatched HLA-DPB1 allele was linked to rs9277534G (high expression) was compared with the risk among recipients whose mismatched HLA-DPB1 allele was linked to rs9277534A (low expression). RESULTS: The mean HLA-DPB1 expression was lower with rs9277534A than with rs9277534G. Among recipients of transplants from donors with rs9277534A-linked HLA-DPB1, the risk of acute GVHD was higher for recipients with rs9277534G-linked HLA-DPB1 mismatches than for recipients with rs9277534A-linked HLA-DPB1 mismatches (hazard ratio, 1.54; 95% confidence interval [CI], 1.25 to 1.89; P<0.001), as was the risk of death due to causes other than disease recurrence (hazard ratio, 1.25; 95% CI, 1.00 to 1.57; P=0.05). CONCLUSIONS: The risk of GVHD associated with HLA-DPB1 mismatching was influenced by the HLA-DPB1 rs9277534 expression marker. Among recipients of HLA-DPB1-mismatched transplants from donors with the low-expression allele, recipients with the high-expression allele had a high risk of GVHD. (Funded by the National Institutes of Health and others.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mismatched HLA-DP has been shown to be associated with graft-versus-host disease (47).”
From Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy (2018) · cites this paper as [47]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analyzing real-time PCR data by the comparative CT method
Schmittgen, T. D., & Livak, K. J. (2008) · Nature Protocols · doi:10.1038/nprot.2008.73 · Cited by 26,190
Graft-versus-leukemia reactions after bone marrow transplantation
Horowitz, M., Gale, R., Sondel, P., Goldman, J., Kersey, J., Kolb, H., Rimm, A., Ringden, O., Rozman, C., & Speck, B. (1990) · Blood · doi:10.1182/blood.v75.3.555.555 · Cited by 2,774
Self-citationFord, R., & Eisenberg, S. (1990) · Nursing Clinics of North America · doi:10.1016/s0029-6465(22)02934-6 · Cited by 2,720
Lee, S. J., Klein, J., Haagenson, M., Baxter-Lowe, L. A., Confer, D. L., Eapen, M., Fernandez-Vina, M., Flomenberg, N., Horowitz, M., Hurley, C. K., et al. (2007) · Blood · doi:10.1182/blood-2007-06-097386 · Cited by 1,255
Self-citationHematopoietic Cell Transplantation
Forman, S. J., & Nakamura, R. (2015) · Blackwell Science Ltd eBooks · Cited by 659
Sasazuki, T., Juji, T., Morishima, Y., Kinukawa, N., Kashiwabara, H., Inoko, H., Yoshida, T., Kimura, A., Akaza, T., Kamikawaji, N., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810223391701 · Cited by 526
Kamatani, Y., Wattanapokayakit, S., Ochi, H., Kawaguchi, T., Takahashi, A., Hosono, N., Kubo, M., Tsunoda, T., Kamatani, N., Kumada, H., et al. (2009) · Nature Genetics · doi:10.1038/ng.348 · Cited by 516
Influence of HLA-C Expression Level on HIV Control
Apps, R., Qi, Y., Carlson, J. M., Chen, H., Gao, X., Thomas, R., Yuki, Y., Del Prete, G. Q., Goulder, P., Brumme, Z. L., et al. (2013) · Science · doi:10.1126/science.1232685 · Cited by 371
Self-citationFleischhauer, K., Shaw, B. E., Gooley, T., Malkki, M., Bardy, P., Bignon, J.-D., Dubois, V., Horowitz, M. M., Madrigal, J. A., Morishima, Y., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70004-9 · Cited by 357
Self-citationMajor-Histocompatibility-Complex Class I Alleles and Antigens in Hematopoietic-Cell Transplantation
Petersdorf, E. W., Hansen, J. A., Martin, P. J., Woolfrey, A., Malkki, M., Gooley, T., Storer, B., Mickelson, E., Smith, A., & Anasetti, C. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011826 · Cited by 335
Self-citation
Cited by
Items 101–200 of 309
Ruggeri, A., de Wreede, L. C., Müller, C., Crivello, P., Bonneville, E. F., Petersdorf, E. W., Socié, G., Dubois, V., Niittyvuopio, R., Peräsaari, J. P., et al. (2022) · Haematologica · doi:10.3324/haematol.2021.280055 · Cited by 24
“These include sharing of alloreactive TCE groups between mismatched HLA-DPB1 alleles (TCE-permissiveness), mainly associated with NRM (3) (8), and high or low expression levels determined by a specific single nucleotide polymorphism (SNP) in the HLA-DPB1 3’untranslated region (expression-permissiveness), mainly associ…”
BackgroundMethodResultInfluentialSelf-citationJohansson, T., Partanen, J., & Saavalainen, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1007425 · Cited by 24
Allotransplants for Patients 65 Years or Older with High-Risk Acute Myeloid Leukemia
Veltri, L. W., Rezvani, K., Oran, B., Mehta, R. S., Rondón, G., Kebriaei, P., Popat, U., Nieto, Y. L., Hosing, C. M., Qazilbash, M. H., et al. (2018) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2018.09.032 · Cited by 24
Optimizing Donor Choice and GVHD Prophylaxis in Allogeneic Hematopoietic Cell Transplantation
Holtan, S. G., Versluis, J., Weisdorf, D. J., & Cornelissen, J. J. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.01771 · Cited by 24
Cornaby, C., Montgomery, M. C., Liu, C., & Weimer, E. T. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.901377 · Cited by 23
Zecher, B. F., Ellinghaus, D., Schloer, S., Niehrs, A., Padoan, B., Baumdick, M. E., Yuki, Y., Martin, M. P., Głów, D., Schröder‐Schwarz, J., et al. (2023) · Gut · doi:10.1136/gutjnl-2023-329524 · Cited by 24
Self-citationHLA Polymorphism in Regressive and Non‐Regressive Autism: A Preliminary Study
Tamouza, R., Fernell, E., Eriksson, M. A., Anderlid, B., Manier, C., Mariaselvam, C. M., Boukouaci, W., Leboyer, M., & Gillberg, C. (2019) · Autism Research · doi:10.1002/aur.2217 · Cited by 23
“…low (rs927753 A) and high (rs927753 G) expressed variants, the HLA-DPB1 polymorphism was found to be extremely relevant in pathological situations such as graft vs. host disease after hematopoietic stem cells transplantation [Petersdorf et al., 2015] or hepatitis B infection [Thomas et al., 2012].”
BackgroundVariation and expression of HLA-DPB1 gene in HBV infection
Ou, G., Liu, X., Xu, H., Liu, X., Liu, X., & Wang, J. (2021) · Immunogenetics · doi:10.1007/s00251-021-01213-w · Cited by 23
Hickey, M. J., Zheng, Y. Y., Valenzuela, N. M., Zhang, Q., Krystal, C., Lum, E. L., Chambers, E. T., Lipshutz, G. S., Gritsch, H. A., Danovitch, G. M., et al. (2016) · Human Immunology · doi:10.1016/j.humimm.2016.10.020 · Cited by 23
Full-length next-generation sequencing of HLA class I and II genes in a cohort from Thailand
Geretz, A., Ehrenberg, P. K., Bouckenooghe, A. R., Fernández-Viña, M., Michael, N. L., Chansinghakule, D., Limkittikul, K., & Thomas, R. (2018) · Human Immunology · doi:10.1016/j.humimm.2018.09.005 · Cited by 23
Casasola-LaMacchia, A., Ritorto, M. S., Seward, R., Ahyi-Amendah, N., Ciarla, A., Hickling, T. P., & Neubert, H. (2021) · Scientific Reports · doi:10.1038/s41598-020-77024-y · Cited by 22
Kopardé, V. N., Razzaq, B. A., Suntum, T., Sabo, R., Scalora, A. F., Serrano, M. G., Jameson‐Lee, M., Hall, C., Kobulnicky, D. J., Sheth, N. U., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187771 · Cited by 22
Current HLA testing recommendations to support HCT
Yu, N., Askar, M. Z., Wadsworth, K., Gragert, L. A., & Fernández-Viña, M. (2022) · Human Immunology · doi:10.1016/j.humimm.2022.04.008 · Cited by 22
Identification of DPB1 Permissive Unrelated Donors Is Highly Likely
Tram, K. V., Stritesky, G. L., Wadsworth, K., Ng, J., Anasetti, C., & Dehn, J. G. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.10.021 · Cited by 22
Virtual and Reality: An Analysis of the UCLA Virtual Crossmatch Exchanges
Locke, A. F., Hickey, M. J., Valenzuela, N. M., Butler, C., Sosa, R. A., Zheng, Y. Y., Gjertson, D., Reed, E. F., & Zhang, Q. (2023) · Transplantation · doi:10.1097/tp.0000000000004586 · Cited by 21
Honegger, J. R., Tedesco, D., Kohout, J. A., Prasad, M. R., Price, A. A., Lindquist, T., Ohmer, S., Moore‐Clingenpeel, M., Grakoui, A., & Walker, C. M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602337113 · Cited by 21
Mytilineos, D., Tsamadou, C., Neuchel, C., Platzbecker, U., Bunjes, D. W., Schub, N., Wagner-Drouet, E., Wulf, G. G., Kröger, N. M., Murawski, N., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.614976 · Cited by 21
“The G allele expression within the mismatched recipient allotype was associated with higher incidence of aGvHD suggesting a dose effect of the mismatched HLA-allotype (15).”
BackgroundPartanen, J., Hyvärinen, K., Bickeböller, H., Bogunia‐Kubik, K., Crossland, R. E., Ivanova, M., Perutelli, F., & Dressel, R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.575492 · Cited by 21
Battle, R. K., Pritchard, D., Peacock, S., Hastie, C., Worthington, J. E., Jordan, S. E., McCaughlan, J. A., Barnardo, M., Cope, R., Collins, C., et al. (2023) · International Journal of Immunogenetics · doi:10.1111/iji.12641 · Cited by 21
Merli, P., Crivello, P., Strocchio, L., Pinto, R. M., Algeri, M., Bufalo, F. D., Pagliara, D., Becilli, M., Carta, R., Gaspari, S., et al. (2022) · British Journal of Haematology · doi:10.1111/bjh.18561 · Cited by 21
Computational assessment of miRNA binding to low and high expression HLA-DPB1 allelic sequences
Shieh, M., Chitnis, N., Clark, P., Johnson, F. B., Kamoun, M., & Monos, D. S. (2018) · Human Immunology · doi:10.1016/j.humimm.2018.09.002 · Cited by 20
Nakatani, K., Ueta, M., Khor, S., Hitomi, Y., Okudaira, Y., Masuya, A., Wada, Y., Sotozono, C., Kinoshita, S., Inoko, H., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-52619-2 · Cited by 20
Bühler, S., Baldomero, H., Ferrari‐Lacraz, S., Mamez, A., Masouridi‐Levrat, S., Heim, D. A., Halter, J. P., Nair, G., Chalandon, Y., Schanz, U., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003998 · Cited by 20
“The cell surface expression of HLA-DPB1 alleles in donors and recipients was inferred from the described linkage between exonic variation and the 3(9) untranslated region rs9277534-G/A polymorphism.(10,19) This allowed the classification of the expression level (ie, respectively high for G-linked alleles and low for A…”
BackgroundResultKlobuch, S., Hammon, K., Vatter, S., Neidlinger, E., Zwerger, M., Wandel, A., Neuber, L. M., Heilmeier, B., Fichtner, R., Mirbeth, C., et al. (2020) · Cells · doi:10.3390/cells9051264 · Cited by 20
“Theses authors showed that a higher expression level of HLA‐DP determined by a genetic variant in the regulatory region of HLA‐DPB1 increases the risk for GvHD after alloHSCT [6].”
BackgroundGenetic risk factors for sclerotic graft-versus-host disease
Inamoto, Y., Martin, P. J., Flowers, M. E. D., Lee, S. J., Carpenter, P. A., Warren, E. H., Geraghty, D. E., Lee, N., Boeckh, M. J., Storer, B. E., et al. (2016) · Blood · doi:10.1182/blood-2016-05-715342 · Cited by 20
HLA Genetics for the Human Diseases
Shiina, T., & Kulski, J. K. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-981-99-9781-7_16 · Cited by 19
Zou, J., Kongtim, P., Oran, B., Kosmoliaptsis, V., Carmazzi, Y., Ma, J., Li, L., Rondón, G., Srour, S. A., Copley, H. C., et al. (2021) · Haematologica · doi:10.3324/haematol.2021.278993 · Cited by 19
Patient HLA Germline Variation and Transplant Survivorship
Petersdorf, E. W., Stevenson, P. A., Malkki, M., Strong, R. K., Spellman, S. R., Haagenson, M. D., Horowitz, M. M., Gooley, T. A., & Wang, T. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.77.6534 · Cited by 19
Self-citationRecent advances in our understanding of the allograft response
Hennessy, C., Lewik, G., Cross, A., Hester, J., & Issa, F. (2021) · Faculty Reviews · doi:10.12703/r/10-21 · Cited by 18
Kulski, J. K., Suzuki, S., Shiina, T., Pfaff, A. L., & Kõks, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1349030 · Cited by 18
“…4), either separately or together, is of interest also for unrelated hematopoietic cell transplantation because the level of expression of HLA-DP in the recipient is an important prognostic indicator of donor-anti-host recognition and for evaluating the risk of graft-versus-host disease (67, 68).”
BackgroundThe impact of next-generation sequencing in immunogenetics: current status and future directions
Bravo-Egaña, V., & Monos, D. S. (2017) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000422 · Cited by 18
Laghmouchi, A., Kester, M. G. D., Hoogstraten, C., Hageman, L., de Klerk, W., Huisman, W., Koster, E. A. S., de Ru, A. H., van Balen, P., Klobuch, S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.831822 · Cited by 18
“They observed in their transplantation model that GvHD is especially expected to occur in patients with highexpression HLA-DP allele(s) transplanted with donors with lowexpression HLA-DP allele(s) (20).”
BackgroundTurner, T. R., Hayward, D. R., Gymer, A. W., Barker, D. J., Leen, G., Cambridge, C. A., Macpherson, H. L., Georgiou, X., Cooper, M., Lucas, J. A. M., et al. (2022) · HLA · doi:10.1111/tan.14571 · Cited by 18
Spierings, E., & Fleischhauer, K. (2018) · Springer eBooks · doi:10.1007/978-3-030-02278-5_9 · Cited by 18
Arrieta‐Bolaños, E., van der Burg, L. L. J., Gedde‐Dahl, T., Robin, M., Salmenniemi, U., Kröger, N. M., Yakoub‐Agha, I., Huynh, A., Crawley, C. R., Deconinck, É., et al. (2024) · Blood · doi:10.1182/blood.2024024351 · Cited by 17
Arumugam, T., Adimulam, T., Gokul, A., & Ramsuran, V. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1422834 · Cited by 17
Use of alternative donors for allogeneic stem cell transplantation
Anasetti, C. (2015) · Hematology · doi:10.1182/asheducation-2015.1.220 · Cited by 17
Lorentino, F., Sacchi, N., Oldani, E., Miotti, V., Picardi, A., Gallina, A. M., Crivello, P., BERNASCONI, P. P., Saccardi, R., Farina, L., et al. (2019) · Haematologica · doi:10.3324/haematol.2019.225177 · Cited by 17
“However, association of these two models with aGvHD risks is in agreement with previous reports from larger studies.(8,9) Second, an apparent difference with previous data from larger studies(3,5) is the lack of association with TCE3.”
BackgroundMethodResultInfluentialSalman, A., Kopardé, V. N., Hall, C. E., Jameson‐Lee, M., Roberts, C. H., Serrano, M. G., Razzaq, B. A., Meier, J. A., Kennedy, C. J., Manjili, M. H., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02284 · Cited by 17
“Indeed, polymorphisms impacting the level of HLA expression correlate with the likelihood of GVHD developing (64).”
BackgroundSelf-citationCucchiari, D., Mancebo, E., Caro, J. L., Meneghini, M., Pérez‐Sáez, M. J., López, B. R., Redondo‐Pachón, D., Arana, C., Bestard, O., Andrés, A., et al. (2025) · Kidney International · doi:10.1016/j.kint.2025.04.031 · Cited by 16
Hoff, G., Fischer, J., Hsu, K. C., Cooley, S., Miller, J. S., Wang, T., Haagenson, M. D., Spellman, S. R., Lee, S. J., Uhrberg, M., et al. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.09.028 · Cited by 16
Self-citationA novel multiplexed 11 locus HLA full gene amplification assay using next generation sequencing
Truong, L., Matern, B. M., D'Orsogna, L. J. A., Martínez, P., Tilanus, M. G. J., & Santis, D. D. (2019) · HLA · doi:10.1111/tan.13729 · Cited by 16
“37 http://www. ebi.ac.uk/imgt/hla),14 the majority of these alleles are defined based on the sequence of exon 2 and 3 for HLA class I genes and exon 2 for HLA class II genes.15 A HLA genotyping method that allows the full gene sequence to be determined is required to complete the reference database and to facilitate t…”
BackgroundInfluentialMismatched unrelated donor transplantation
Petersdorf, E. W. (2016) · Seminars in Hematology · doi:10.1053/j.seminhematol.2016.07.003 · Cited by 16
Self-citationSeitz, A., Mounsey, K., Hughes, P. J., Cullen, K., Smith, M. W., Daga, S., Carter, C. R. D., Clark, B., & Baker, R. J. (2022) · Kidney International Reports · doi:10.1016/j.ekir.2022.07.014 · Cited by 15
“These single nucleotide polymorphisms have been described to be in linkage disequilibrium with certain HLA-DPB1 alleles in Caucasians.(15) DPDSA patients were categorized into low and high expression groups inferred from the donor HLA-DPB1 alleles.”
BackgroundResultInfluentialMoyer, A. M., Hashmi, S. K., Kroning, C. M., Kremers, W. K., Goey, S. R. D., Patnaik, M. M., Litzow, M. R., Gastineau, D. A., Hogan, W. J., Jacob, E. K., et al. (2017) · European Journal Of Haematology · doi:10.1111/ejh.12916 · Cited by 15
Continue to focus clinical decision-making on the antigen recognition domain for the present
Hurley, C. K., & Ng, J. (2018) · Human Immunology · doi:10.1016/j.humimm.2018.04.010 · Cited by 15
A cis-eQTL of HLA-DPB1 Affects Susceptibility to Type 1 Autoimmune Hepatitis
Yamazaki, T., Umemura, T., Joshita, S., Yoshizawa, K., Tanaka, E., & Ôta, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-30406-9 · Cited by 14
Novel HLA-DP region susceptibility loci associated with severe acute GvHD
Goyal, R. K., Lee, S. J., Wang, T., Trucco, M., Haagenson, M. D., Spellman, S. R., Verneris, M. R., & Ferrell, R. E. (2016) · Bone Marrow Transplantation · doi:10.1038/bmt.2016.210 · Cited by 14
Self-citationFleischhauer, K., Hsu, K. C., & Shaw, B. E. (2018) · Bone Marrow Transplantation · doi:10.1038/s41409-018-0218-1 · Cited by 14
Gadalla, S. M., Wang, Y., Wang, T., Onabajo, O. O., Banday, A. R., Obajemu, A. A., Karaesman, E., Sucheston‐Campbell, L. E., Hahn, T., Sees, J. A., et al. (2020) · The Lancet Haematology · doi:10.1016/s2352-3026(20)30294-5 · Cited by 14
Self-citationNew insights into the understanding of MHC associations with immune‐mediated disorders
Caillat‐Zucman, S. (2016) · HLA · doi:10.1111/tan.12947 · Cited by 14
“Variation in the 3′UTR of HLA-DPB1 is also associated with DPB1 expression and correlates with spontaneous clearance of hepatitis B virus (22) and with the risk of GVHD (23).”
BackgroundArrieta‐Bolaños, E., Crivello, P., Metzing, M., Meurer, T., Ahci, M., Rytlewski, J. A., Vignali, M., Yusko, E. C., van Balen, P., Horn, P. A., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00280 · Cited by 14
“This feature is desirable for the therapeutic effect of HSCT: moderate alloreactivity levels combined with a sufficiently broad repertoire maximizing the capacity of donor-derived T cells of effectively recognizing malignant patient cells while minimizing GvHD.”
BackgroundInfluentialBasics of Hematopoietic Cell Transplantation for Primary Care Physicians and Internists
Hashmi, S. K. (2016) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2016.07.003 · Cited by 13
van Balen, P., van Luxemburg-Heijs, S. A. P., van de Meent, M., van Bergen, C. A. M., Halkes, C. J. M., Jedema, I., & Falkenburg, J. H. F. (2017) · Transplantation · doi:10.1097/tp.0000000000001713 · Cited by 13
Measuring alloantibodies: a matter of quantity and quality
Kiernan, J., Ellison, C. A., & Tinckam, K. J. (2018) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000593 · Cited by 13
Sajulga, R., Bolon, Y., Maiers, M. J., & Petersdorf, E. W. (2023) · Blood Advances · doi:10.1182/bloodadvances.2022009554 · Cited by 13
“Conversely, high HLA-DP expression mismatches are highrisk and unfavorable.(16) HLA-DP expression is associated with the rs9277534 single nucleotide polymorphism (SNP) in the 3′ untranslated region (UTR), in which the rs9277534A allele correlates with low expression, and the rs9277534G allele with high expression.”
BackgroundMethodInfluentialSelf-citationNKp44/HLA-DP-dependent regulation of CD8 effector T cells by NK cells
Padoan, B., Casar, C., Krause, J., Schultheiß, C., Baumdick, M. E., Niehrs, A., Zecher, B. F., Pujantell, M., Yuki, Y., Martin, M. P., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114089 · Cited by 14
“57,58 HCMV infection represents an important risk factor for the development of T1D.”
BackgroundSelf-citationFrom genetic single candidate gene studies to complex genomics of GvHD
Bogunia‐Kubik, K., & Łacina, P. (2017) · British Journal of Haematology · doi:10.1111/bjh.14704 · Cited by 13
“…by the T-cell epitope matching algorithm (Zino et al, 2004) or by taking into account the level of DP expression tagged by the rs9277534 single nucleotide polymorphism (SNP) associated with HLA-DPB1 expression and reported to be correlated with increased risk of aGvHD (Petersdorf et al, 2015).”
BackgroundTargeted RNA-Based Oxford Nanopore Sequencing for Typing 12 Classical HLA Genes
Johansson, T., Koskela, S., Yohannes, D. A., Partanen, J., & Saavalainen, P. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.635601 · Cited by 13
Generation and expression analysis of BAC humanized mice carrying HLA‐DP401 haplotype
Li, F., Zhu, M., Niu, B., Liu, L., Peng, X., Yang, H., Qin, B., Wang, M., Ren, X., & Zhou, X. (2021) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12158 · Cited by 13
Suzuki, S., Morishima, S., Murata, M., Tanaka, M., Shigenari, A., Ito, S., Kanga, U., Kulski, J. K., Morishima, Y., & Shiina, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.938206 · Cited by 12
“In the HLA genomic region, HLA-DPB1 has been characterized as an aGVHD-related HLA locus, as follows: 1) HLA-DPB1 mismatch associates with severe aGVHD (15, 17), 2) T-cell epitope (TCE) algorism of DPB1 (18), 3) highly expressed HLA-DPB1 alleles associate with aGVHD (19), and 4) evolutionarily highly conserved gene st…”
BackgroundMontgomery, M. C., Petraroia, R., & Weimer, E. T. (2017) · Human Immunology · doi:10.1016/j.humimm.2017.08.003 · Cited by 12
Linjama, T., Räther, C., Ritari, J., Peräsaari, J. P., Eberhard, H., Korhonen, M. O., & Koskela, S. (2019) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2019.07.008 · Cited by 12
HLA genotyping by next-generation sequencing of complementary DNA
Segawa, H., Kukita, Y., & Kato, K. (2017) · BMC Genomics · doi:10.1186/s12864-017-4300-7 · Cited by 12
Koskela, S., Ritari, J., Hyvärinen, K., Kwan, T., Niittyvuopio, R., Itälä‐Remes, M., Pastinen, T., & Partanen, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-23682-y · Cited by 12
Balgansuren, G., Regen, L. E., Sprague, M., Shelton, N., Petersdorf, E. W., & Hansen, J. A. (2019) · Human Immunology · doi:10.1016/j.humimm.2019.05.010 · Cited by 11
Self-citationNew strategies for mismatched unrelated donor (MMUD) hematopoietic cell transplant (HCT)
Arslan, S., & Malki, M. M. A. (2022) · Hematology · doi:10.1182/hematology.2022000398 · Cited by 11
Bettens, F., Bühler, S., & Tiercy, J. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00584 · Cited by 11
“Specific HLA-DPB1 MMs with higher potential for T cell allorecognition, as well as expression levels of HLA-DPB1 variants, have been reported to be associated with acute GVHD in unrelated HSCT (21, 22).”
BackgroundInfluentialLaghmouchi, A., Hoogstraten, C., van Balen, P., Falkenburg, J. H. F., & Jedema, I. (2018) · Haematologica · doi:10.3324/haematol.2018.193680 · Cited by 11
“The magnitude of the T-cell response mounted against allo-HLA-DP molecules has been shown to be different depending on the specific HLA-DP allele(s) expressed in the donor and the patient.(25,26) Differences at the amino acid sequence level have been found to influence the immunogenicity of specific HLA-DP molecules,…”
BackgroundUnrelated Donor Hematopoietic Cell Transplantation
Petersdorf, E. W., & Anasetti, C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35762-3.00105-0 · Cited by 11
Self-citationArtificial Intelligence in Hematopoietic Stem Cell Transplantation Care and Complication Management
Turki, A. T., Mussetti, A., Scheidler, K. M., Kehrmann, J., Crivello, P., Hosch, R., Nensa, F., & Polizzi, S. (2025) · Acta Haematologica · doi:10.1159/000547767 · Cited by 10
“The differential expression of alleles at the HLA-C and HLA-DPB1 loci [86, 87], as well as the role of HLA as an inhibitory ligand for natural killer cells and the corresponding killer cell immunoglobulin-like receptors in the donor, were explored [88, 89].”
Crocchiolo, R., & Rombolà, G. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12020646 · Cited by 10
“Beyond the cited HLA loci, DPB1 matching has been extensively studied in alloHSCT, and some combinations (referred to as permissive) demonstrated to be better tolerated than others, based on the immunogenicity of the associated T-cell epitopes [12–14] and HLA expression [15,16].”
BackgroundArrieta‐Bolaños, E. (2024) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2024.101575 · Cited by 10
Malki, M. M. A., Gendzekhadze, K., Stiller, T., Mokhtari, S., Karanes, C., Parker, P. M., Snyder, D., Forman, S. J., Nakamura, R., & Nademanee, A. P. (2019) · Bone Marrow Transplantation · doi:10.1038/s41409-019-0694-y · Cited by 10
“A single-nucleotide polymorphism (SNP) in HLA-DPB1 regulatory region variant rs9277534 is associated with HLA-DPB1 cell-surface expression [7, 8], and Petersdorf et al.”
BackgroundResultInfluentialFleischhauer, K. (2019) · Hematology · doi:10.1182/hematology.2019000057 · Cited by 10
“†Data are from Petersdorf et al.(13) Baseline is the 8/8 transplants with a single HLA-DPB1 mismatch in the graft-versus-host direction, where the mismatched allele in the donor carried the SNP proxy A and the mismatched allele in the recipient also carried the SNP proxy A (n 5 413), against the same type of pairing b…”
BackgroundLundtoft, C., Knight, A., Meadows, J. R. S., Karlsson, Å., Rantapää‐Dahlqvist, S., Berglin, E. H., Palm, Ø., Haukeland, H., Gunnarsson, I., Bruchfeld, A. N., et al. (2024) · RMD Open · doi:10.1136/rmdopen-2023-004039 · Cited by 9
“Web resources IPD-IMGT/HLA: https://www.ebi.ac.uk/ipd/imgt/hla/ RCSB Protein data bank: https://www.rcsb.org/ LDlink: https://ldlink.nci.nih.gov/ Allele frequency Net Database: https://allelefrequen-cies.net/”
BackgroundCunha, R., Zago, M. A., Querol, S., Volt, F., Ruggeri, A., Sanz, G. F., Pouthier, F., Kögler, G., Vicario, J. L., Bergamaschi, P., et al. (2016) · Blood · doi:10.1182/blood-2016-06-722249 · Cited by 9
HLA structure and function in hematopoietic-cell transplantation
Petersdorf, E. W. (2024) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2024.101564 · Cited by 8
Self-citationRegulatory noncoding RNAs and the major histocompatibility complex
Chitnis, N., Shieh, M., & Monos, D. S. (2020) · Human Immunology · doi:10.1016/j.humimm.2020.06.005 · Cited by 8
Martin, P. J., Levine, D., Storer, B. E., Sather, C. L., Spellman, S. R., & Hansen, J. A. (2022) · Blood Advances · doi:10.1182/bloodadvances.2021005620 · Cited by 8
“Tacrolimus and methotrexate 608 (14) 183 (10) 303 (21)”
Self-citationHLA antibodies in haematopoietic stem cell transplantation
Little, A. (2019) · HLA · doi:10.1111/tan.13741 · Cited by 8
Shieh, M., Hayeck, T. J., Dinh, A., Duke, J. L., Chitnis, N., Mosbruger, T. L., Morlen, R. P., Ferriola, D., Kneib, C., Hu, T., et al. (2020) · Transplantation · doi:10.1097/tp.0000000000003272 · Cited by 8
“In the setting of HSCT, presence of a HLA-DPB1 mismatch between a G-linked patient allele and an A-linked donor allele was shown to be associated with GVHD.(7) In SOT, MM load has been established as a strong predictor of DSA development and subsequent graft failure.”
BackgroundInfluentialPicardi, A., Sacchi, N., Miotti, V., Lorentino, F., Oldani, E., Rambaldi, A., Sessa, M., Bruno, B., Cerno, M., Vago, L., et al. (2021) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2020.11.021 · Cited by 8
Sajulga, R., Madbouly, A. S., Fingerson, S., Gragert, L. A., Bashyal, P., Bolon, Y., & Maiers, M. J. (2021) · Human Immunology · doi:10.1016/j.humimm.2021.06.010 · Cited by 8
Cambridge, C. A., Turner, T. R., Georgiou, X., Robinson, J., Mayor, N. P., & Marsh, S. G. E. (2023) · HLA · doi:10.1111/tan.15261 · Cited by 7
“12,13 Finally, matching at the ultra-high resolution level has been associated with improved over-all survival in HCT, 5,14,15 with matching at this level believed to be closer to a full haplotype match across the wider MHC region.”
BackgroundRambaldi, B., Rizzuto, G., Rambaldi, A., & Introna, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1459175 · Cited by 7
Habets, T. H. P. M., Hepkema, B. G., Kouprie, N., Schnijderberg, M. C. A., van Smaalen, T. C., Bungener, L. B., Christiaans, M. H. L., Bos, G. M. J., & Vanderlocht, J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203381 · Cited by 7
“Petersdorf et al . reported that the expression level of HLA-C and HLA-DP is of significant importance in influencing the strength of alloimmune responses in recipients that had mismatched HLA loci [26, 28].”
de Marco, R., Requião‐Moura, L., Raimundo, T. R. F., Mourão, T. B., Rampim, G. F., Medina-Pestana, J. O., Junior, H. T. S., & Gerbase‐DeLima, M. (2022) · HLA · doi:10.1111/tan.14911 · Cited by 7
“18–20 Conversely, the expression MM involves single nucleotide polymorphism (SNP) rs9277534 located in the 30 untranslated region of the HLA-DPB1 gene, which correlates with the expression level of HLADP molecules.(21,22) Only two studies addressed the impact of HLADPB1 mMM on outcomes in the kidney transplant setting.”
BackgroundHLA‐B leader genotypes in a clinical population
Balgansuren, G., Sprague, M., Peterson, P., Shenavar, Y., Ng, A., Regen, L. E., Shelton, N., & Petersdorf, E. W. (2023) · HLA · doi:10.1111/tan.15022 · Cited by 7
Self-citationSeshasubramanian, V., Venugopal, M., Kannan, A. D. S., Naganathan, C., Manisekar, N. K., Kumar, Y. N., Narayan, S., & Periathiruvadi, S. (2019) · HLA · doi:10.1111/tan.13565 · Cited by 7
“Intron regions play an important role in regulating gene expression.26,27 Furthermore, the role of intron sequences in HLA expression and their importance in HSCT have been shown for HLA-C and HLA-DP.28,29 In addition, NGS becomes cost-effective when higher number of samples are processed.30 NGS technique has been pro…”
BackgroundDifferential Alloreactivity: Lessons Learned From a Singular HLA Locus
Arrieta‐Bolaños, E. (2025) · HLA · doi:10.1111/tan.70489 · Cited by 6
“This role was later investigated in HCT and shown to be associated with increased risk of graft- versus-host disease [99, 100].”
Donor Selection for Adults and Pediatrics
Ayuk, F. A., Balduzzi, A., & Worel, N. (2024) · Springer eBooks · doi:10.1007/978-3-031-44080-9_12 · Cited by 6
Role of HLA-DP in the Presentation of Epitopes from the Truncated Bacterial PE38 Immunotoxin
Mazor, R., Addissie, S., Jang, Y., Tai, C., Rose, J. J., Hakim, F. T., & Pastan, I. H. (2016) · The AAPS Journal · doi:10.1208/s12248-016-9986-y · Cited by 6
“To understand the mechanism of preferable DP presentation, we examined whether higher expression of DP molecules, which has been shown to be linked to a genetic polymorphism in the HLA-DPB1 gene regulatory region (48), could affect the restriction of the epitopes in our ex vivo settings.”
Truong, L., Matern, B. M., Groeneweg, M., D'Orsogna, L. J. A., Martínez, P., Tilanus, M. G. J., & Santis, D. D. (2020) · HLA · doi:10.1111/tan.13975 · Cited by 6
Donor CTLA-4 Genotype Modulates the Immune Response to Minor Histocompatibility Antigen Mismatches
Gallardo, D., Bosch-Vizcaya, A., Rodríguez-Romanos, R., Santos, N., Buño, I., de la Cámara, R., Brunet, S., Jiménez‐Velasco, A., González, M., Nieto, J. B., et al. (2017) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2017.08.003 · Cited by 6
Next-generation sequencing of 11 HLA loci in a large dengue vaccine cohort from the Philippines
Geretz, A., Cofer, L., Ehrenberg, P. K., Currier, J. R., Yoon, I., Alera, M. T., Jarman, R. G., Rothman, A. L., & Thomas, R. (2020) · Human Immunology · doi:10.1016/j.humimm.2020.06.010 · Cited by 6
Dong, L., Zhao, S., Chen, N., Xu, J., & Zhu, F. (2022) · HLA · doi:10.1111/tan.14601 · Cited by 6
Tripathi, G., Khanolkar, R. A., Faridi, R. M., Kalra, A., Dharmani‐Khan, P., Shabani‐Rad, M., Berka, N., Daly, A. S., Storek, J., & Khan, F. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415888 · Cited by 6
“Since the conception of the study, evidence has emerged supporting the role of other HLA-loci including HLA-DPB1 in GVHD pathogenesis [53,54].”
BackgroundMahdi, B. M. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.73938 · Cited by 6
Chen, D., Chang, S., Jaing, T., Wang, W., Hsu, F.-P., & Tseng, C. (2021) · Scientific Reports · doi:10.1038/s41598-021-01155-z · Cited by 6
Metadata
- Authors
- Petersdorf, E. W., Malkki, M., O’hUigin, C., Carrington, M., Gooley, T., Haagenson, M. D., Horowitz, M. M., Spellman, S. R., Wang, T., & Stevenson, P.
- Affiliations
- University of Washington (US)
- Fred Hutch Cancer Center (US)
- Ragon Institute of MGH, MIT and Harvard (US)
- Medical College of Wisconsin (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-08-13
- Volume
- 373
- Issue
- 7
- Pages
- 599-609
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC4560117
- OpenAlex
- W2258080942
- Cited by
- 278
- References
- 32
- Citations by year
- 2026: 12 · 2025: 9 · 2024: 26 · 2023: 18 · 2022: 20 · 2021: 25 · 2020: 24 · 2019: 33 · 2018: 36 · 2017: 41 · 2016: 30 · 2015: 3
- FWCI
- 28.78
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Department of Defense (N000141310039)
- Frederick National Laboratory for Cancer Research (HHSN261200800001E.)
- National Institutes of Health (N00014-12-1-0142, #HHSN261200800001E, HHSN261200800001C, CA 18029)
- U.S. Public Health Service (HHSH234200637015C)
- U.S. Navy
- National Heart, Lung, and Blood Institute (U01HL069294)
- Office of Naval Research (N00014-13-1-0039, N00014-14-1-0028, N00014-12-1-0142, N00014-12-1, N00014)
- National Cancer Institute (CA18029, U24CA76518, HHSN261200800001E), CA76518, CA100019, P30CA015704, U24CA076518, R01CA100019, P01CA018029)
- National Institute of Allergy and Infectious Diseases (AI069197, U01AI069197)
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Keywords
- HLA-DPB1, HLA-DPB1 mismatch, unrelated donor transplantation, post-transplant mortality, hematopoietic stem cell transplantation
- MeSH terms
- Adolescent, Adult, Female, Genotype, Graft vs Host Disease, Histocompatibility Testing, Humans, Genetic Linkage, Male, Middle Aged, Regulatory Sequences, Nucleic Acid, Proportional Hazards Models, Polymerase Chain Reaction, Hematopoietic Stem Cell Transplantation, Polymorphism, Single Nucleotide, Young Adult, HLA-DP beta-Chains, Unrelated Donors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.